Literature DB >> 9137086

Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.

R Dolcetti1, R Giardini, C Doglioni, R Cariati, F Pomponi, C D'Orazi, S Rao, A I Lazarovits, E C Butcher, M Boiocchi.   

Abstract

We have previously shown that the in vivo coordinated expression of individual alpha 4 and beta 7 integrin chains correlated with the leukemic potential displayed by cell lines derived from murine lymphoblastic T-cell lymphomas (T-LBLs) when transplanted subcutaneously into syngeneic AKR mice. In the present study, by using immunofluorescence and immunocytochemical analyses, we have confirmed that the in vivo up-regulation of the alpha 4 beta 7 heterodimeric complex is associated with the leukemic behavior of AKR T-LBLs. In addition, when compared with the parental, highly leukemic NQ22 cells, the variant cell line NQ22V exhibited a reduced leukemic potential that was invariably associated with a delayed alpha 4 beta 7 up-regulation in vivo Moreover, the leukemic cell line SJ-1, derived from a spontaneous T-LBL of the SJL strain, also displayed high levels of alpha 4 beta 7 expression with a pattern of tissue distribution similar to that of NQ22 cells from leukemic AKR animals. Of note, in most of the tissues involved by murine T-LBL dissemination, and particularly in liver, kidney, and lung, alpha 4 beta 7-positive leukemic cells were always located around strongly VCAM-1-positive vascular spaces. These findings are consistent with a possible role of alpha 4 beta 7/VCAM-1 interactions in the extravasation and, consequently, in the leukemic dissemination of murine T-LBL cells. Immunocytochemical analysis carried out in 11 human T-LBLs showed that pathological lymph nodes from all 7 cases with bone marrow infiltration at presentation carried alpha 4 beta 7-positive cells, whereas all 4 aleukemic T-LBLs were repeatedly alpha 4 beta 7 negative, also in metachronous lesions. These findings suggest that alpha 4 beta 7-positive human T-LBLs may represent a distinct clinicopathological entity. In addition, alpha 4 beta 7 expression was significantly more prevalent in younger patients (< 11 years; P = 0.02), further supporting such a hypothesis. Moreover, as in murine T-LBLs, the pattern of alpha 4 beta 7 positivity in involved lymph nodes was mainly focal, whereas nearly all neoplastic cells infiltrating bone marrow expressed this integrin, suggesting a possible role for alpha 4 beta 7 in the leukemic dissemination also of human T-LBLs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9137086      PMCID: PMC1858193     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  The integrin VLA-4 supports tethering and rolling in flow on VCAM-1.

Authors:  R Alon; P D Kassner; M W Carr; E B Finger; M E Hemler; T A Springer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

Review 2.  The pathophysiologic role of alpha 4 integrins in vivo.

Authors:  R R Lobb; M E Hemler
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

3.  Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo.

Authors:  A Hamann; D P Andrew; D Jablonski-Westrich; B Holzmann; E C Butcher
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

4.  Development of myelosarcomas from human myelogenous leukemia cells transplanted in athymic mice.

Authors:  E A Machado; B B Lozzio; C B Lozzio; S V Lair; M C Aggio
Journal:  Cancer Res       Date:  1977-11       Impact factor: 12.701

Review 5.  Acute lymphoblastic leukemia and the lymphoblastic lymphomas of childhood.

Authors:  D R Head; F G Behm
Journal:  Semin Diagn Pathol       Date:  1995-11       Impact factor: 3.464

Review 6.  Integrin mediated signal transduction in oncogenesis: an overview.

Authors:  S Dedhar
Journal:  Cancer Metastasis Rev       Date:  1995-09       Impact factor: 9.264

7.  Acute lymphoblastic leukemia and non-Hodgkin's lymphoma with mediastinal mass--a study of 23 children; different disorders or different stages?

Authors:  T Shikano; H Arioka; R Kobayashi; H Naito; Y Ishikawa; H Nakadate; Y Hatae; T Takeda
Journal:  Leuk Lymphoma       Date:  1994-03

Review 8.  Growth factor regulation of integrin-mediated cell motility.

Authors:  K Matsumoto; B L Ziober; C C Yao; R H Kramer
Journal:  Cancer Metastasis Rev       Date:  1995-09       Impact factor: 9.264

9.  alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow.

Authors:  C Berlin; R F Bargatze; J J Campbell; U H von Andrian; M C Szabo; S R Hasslen; R D Nelson; E L Berg; S L Erlandsen; E C Butcher
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

10.  Growth of acute myeloid leukaemia as discrete subcutaneous tumours in immune-deprived mice.

Authors:  C R Franks; D Bishop; F R Balkwill; R T Oliver; W G Spector
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

View more
  4 in total

1.  Homing receptor alpha4beta7 integrin expression predicts digestive tract involvement in mantle cell lymphoma.

Authors:  F Geissmann; A Ruskoné-Fourmestraux; O Hermine; P Bourquelot; C Belanger; J Audouin; A Delmer; E A Macintyre; B Varet; N Brousse
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

2.  Identification of an adhesion molecule expressed on adult T cell leukemia cells derived from a patient with gastrointestinal involvement: implication for a possible role of integrin beta 7 in leukemic cell infiltration into intestinal mucosa.

Authors:  H Chen; T Hori; M Maeda; T Uchiyama
Journal:  J Clin Immunol       Date:  1999-05       Impact factor: 8.317

3.  Intestinal T lymphocyte homing is associated with gastric emptying and epithelial barrier function in critically ill: a prospective observational study.

Authors:  Christian Greis; Zohal Rasuly; Rolf A Janosi; Lambros Kordelas; Dietrich W Beelen; Tobias Liebregts
Journal:  Crit Care       Date:  2017-03-22       Impact factor: 9.097

Review 4.  Cadherins, Selectins, and Integrins in CAM-DR in Leukemia.

Authors:  Hye Na Kim; Yongsheng Ruan; Heather Ogana; Yong-Mi Kim
Journal:  Front Oncol       Date:  2020-12-10       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.